Label: TERBINAFINE HYDROCHLORIDE cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated September 27, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient

    Terbinafine hydrochloride 1%

  • Purpose

    Antifungal

  • Uses

    •
    cures most athlete's foot (tinea pedis)
    •
    cures most jock itch (tinea cruris) and ringworm (tinea corporis)
    •
    relieves itching, burning, cracking and scaling which accompany these conditions
  • Warnings

    For external use only

    Do not use

    •
    on nails or scalp
    •
    in or near the mouth or the eyes
    •
    for vaginal yeast infections

    When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water.

    Stop use and ask a doctor if

    •
    too much irritation occurs or gets worse.
    •
    side effects occur. You may report side effects to FDA at 1-800-FDA-1088.

    Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.

  • Directions

    •
    adults and children 12 years and older
    •
    use the tip of the cap to break the seal and open the tube
    •
    wash the affected skin with soap and water and dry completely before applying
    •
    for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily.
    •
    between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor.
    •
    on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor.
    •
    for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor.
    •
    wash hands after each use
    •
    children under 12 years: ask a doctor

    1 week between the toes
    Figure 1
    2 weeks on the bottom or sides of the foot
    Figure 2
  • Other information

    •
    do not use if seal on tube is broken or is not visible
    •
    store at controlled room temperature 20°-25°C (68°-77°F)
    •
    see carton or tube crimp for lot number and expiration date
  • Inactive ingredients

    benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.

  • SPL UNCLASSIFIED SECTION

    Distributed by:
    Taro Pharmaceuticals U.S.A., Inc.
    Hawthorne, NY 10532

    Relabeled By: Preferred Pharmaceuticals Inc.

  • PRINCIPAL DISPLAY PANEL - 30 g Carton

    Cures Most Athlete's Foot
    Terbinafine Hydrochloride
    Cream 1%
    Antifungal Cream

    Full Prescription Strength

    NET WT 1 oz (30 g)

    Terbinafine Hydrochloride Cream 1%
  • INGREDIENTS AND APPEARANCE
    TERBINAFINE HYDROCHLORIDE 
    terbinafine hydrochloride cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68788-9814(NDC:51672-2080)
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Terbinafine Hydrochloride (UNII: 012C11ZU6G) (Terbinafine - UNII:G7RIW8S0XP) Terbinafine Hydrochloride1 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    benzyl alcohol (UNII: LKG8494WBH)  
    cetyl alcohol (UNII: 936JST6JCN)  
    cetyl palmitate (UNII: 5ZA2S6B08X)  
    isopropyl myristate (UNII: 0RE8K4LNJS)  
    polysorbate 60 (UNII: CAL22UVI4M)  
    water (UNII: 059QF0KO0R)  
    sodium hydroxide (UNII: 55X04QC32I)  
    sorbitan monostearate (UNII: NVZ4I0H58X)  
    stearyl alcohol (UNII: 2KR89I4H1Y)  
    Product Characteristics
    ColorWHITEScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68788-9814-115 g in 1 TUBE; Type 0: Not a Combination Product04/05/2012
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07751104/05/2012
    Labeler - Preferred Pharmaceuticals, Inc (791119022)
    Registrant - Preferred Pharmaceuticals, Inc (791119022)
    Establishment
    NameAddressID/FEIBusiness Operations
    Preferred Pharmaceuticals, Inc791119022RELABEL(68788-9814)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!